Compartmental immunophenotyping in COVID-19 ARDS: A case series.

"Disclosure of potential conflict of interest: T. Benfield reports personal fees and nonfinancial support from Bristol-Myers Squibb and Gilead. The rest of the authors declare that they have no relevant conflicts of interest."

"This study was supported by the 10.13039/501100003554Lundbeck Foundation (grant R349-2020-540)."

"For inclusion in this cross-sectional study, participants had to be adults (≥18 years) with SARS-CoV-2 confirmed by PCR, with presence of ARDS determined according to the Berlin criteria and less than 72 hours of mechanical ventilation after admittance to the intensive care unit (ICU). All patients were sedated and unable to provide informed consent, which was obtained from their next of kin. The study was approved by the Regional Ethics Committee of Copenhagen (H-20023159) and the Knowledge Center for Data Review of Copenhagen (P-2020-399) and registered at ClinicalTrials.gov (NCT04354584). A Consolidated Standards of Reporting Trials checklist and flow diagram are provided in and (both of which are available in the Online Repository at www.jacionline.org), respectively."